Pharmaceutical

Antheia Announces New Funding to Support Domestic Production of Critical Pharmaceutical Ingredients

Company awarded government project agreement to onshore key pharmaceutical supply chains, alongside strategic investment from In-Q-Tel and Echo MENLO PARK,…

1 year ago

Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Rule

CHICAGO, IL / ACCESSWIRE / July 19, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

1 year ago

Bausch Health Welcomes Two New Members to the Executive Leadership Team

LAVAL, QC / ACCESSWIRE / July 19, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the appointment of two…

1 year ago

Join Nutriband’s Exclusive Live Investor Webinar and Q&A Session on July 25

ORLANDO, FL / ACCESSWIRE / July 19, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical solutions, is pleased…

1 year ago

Announces Pricing of $5.0 Million Registered Direct Offering and Concurrent Private Placement

July 19, 2024 Biodexa Pharmaceuticals PLC Announces Pricing of $5.0 Million Registered Direct Offering and Concurrent Private Placement Biodexa Pharmaceuticals…

1 year ago

Palisade Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent for Lead Product Candidate, PALI-2108

Patent includes Composition of Matter claims for both PALI-2108 and PALI-1908 programs Patent includes broad claims for “Gut Microbiota Bioactivated…

1 year ago

60 Degrees Pharmaceuticals Signs Clinical Trial Agreements With All Planned Trial Sites for Tafenoquine Babesiosis Study

The Tafenoquine for Babesiosis clinical trial will be conducted at three sites: Yale University, Rhode Island Hospital and Tufts Medical…

1 year ago

Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

SARASOTA, FL, July 19, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage…

1 year ago

Daré Bioscience Regains Compliance with Nasdaq Minimum Bid Price Rule

SAN DIEGO, July 19, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing…

1 year ago

SIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX®

Exercise of Procurement Option under Current Contract Reflects Continuing Action to Enhance Orthopoxvirus PreparednessNEW YORK, July 19, 2024 (GLOBE NEWSWIRE)…

1 year ago